A Progressive Mouse Model of Parkinson’s Disease: The Thy1-aSyn (“Line 61”) Mice

Gait alterations in healthy carriers of the LRRK2 G2019S mutation

(2011) Anat Mirelman et al.   ANNALS OF NEUROLOGY

PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease

(2011) Joo-Ho Shin et al.   CELL

 -Syn Suppression Reverses Synaptic and Memory Defects in a Mouse Model of Dementia with Lewy Bodies

(2011) Y. Lim et al.   JOURNAL OF NEUROSCIENCE

Enhanced Phosphatase Activity Attenuates  -Synucleinopathy in a Mouse Model

(2011) K.-W. Lee et al.   JOURNAL OF NEUROSCIENCE

Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α-synuclein

(2011) Hoa A. Lam et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Modelling of Parkinson's disease in mice

(2011) Marie-Françoise Chesselet et al.   LANCET NEUROLOGY

Priorities in Parkinson's disease research

(2011) Wassilios G. Meissner et al.   NATURE REVIEWS DRUG DISCOVERY

Genome-Wide Gene-Environment Study Identifies Glutamate Receptor Gene GRIN2A as a Parkinson's Disease Modifier Gene via Interaction with Coffee

(2011) Taye H. Hamza et al.   PLoS Genetics

Genome-Wide Association Study Confirms SNPs inSNCAand theMAPTRegion as Common Risk Factors for Parkinson Disease

(2010) Todd L. Edwards et al.   ANNALS OF HUMAN GENETICS

Clinical progression in Parkinson disease and the neurobiology of axons

(2010) Hsiao-Chun Cheng et al.   ANNALS OF NEUROLOGY

Balance is the challenge - The impact of mitochondrial dynamics in Parkinson’s disease

(2010) Lena F. Burbulla et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated α-synuclein gene mutations precede central nervous system changes

(2010) Yien-Ming Kuo et al.   HUMAN MOLECULAR GENETICS

Transgenic animal models of neurodegeneration based on human genetic studies

(2010) Brandon K. Harvey et al.   JOURNAL OF NEURAL TRANSMISSION

TRO40303, a New Cardioprotective Compound, Inhibits Mitochondrial Permeability Transition

(2010) S. Schaller et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions

(2010) Sheila M. Fleming et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

Dopamine turnover increases in asymptomatic LRRK2 mutations carriers

(2010) Vesna Sossi et al.   MOVEMENT DISORDERS

Parkinson's disease: a model dilemma

(2010) M. Flint Beal   NATURE

The Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons

(2010) Hakeem O. Lawal et al.   NEUROBIOLOGY OF DISEASE

α-Synuclein Gene May Interact with Environmental Factors in Increasing Risk of Parkinson’s Disease

(2010) Nicole M. Gatto et al.   NEUROEPIDEMIOLOGY

Genetic Animal Models of Parkinson's Disease

(2010) Ted M. Dawson et al.   NEURON

Dopamine Transporter Genetic Variants and Pesticides in Parkinson’s Disease

(2009) Beate R. Ritz et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

Paraoxonase 1, Agricultural Organophosphate Exposure, and Parkinson Disease

(2009) Angelika D. Manthripragada et al.   EPIDEMIOLOGY

Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein

(2009) Franz Marxreiter et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Lovastatin ameliorates α-synuclein accumulation and oxidation in transgenic mouse models of α-synucleinopathies

(2009) Andrew O. Koob et al.   EXPERIMENTAL NEUROLOGY

Clinical neuroprotection in Parkinson's disease — Still waiting for the breakthrough

(2009) Matthias Löhle et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Medical records documentation of constipation preceding Parkinson disease: A case-control study

(2009) R. Savica et al.   NEUROLOGY

The scientific and clinical basis for the treatment of Parkinson disease (2009)

(2009) C. W. Olanow et al.   NEUROLOGY

Abnormal colonic motility in mice overexpressing human wild-type α-synuclein

(2009) Lixin Wang et al.   NEUROREPORT

Alterations in corticostriatal synaptic plasticity in mice overexpressing human α-synuclein

(2009) J.B. Watson et al.   NEUROSCIENCE

Targeting neuroprotection as an alternative approach to preventing and treating neuropathic pain

(2009) Thierry Bordet et al.   Neurotherapeutics

Toxic effects of dopamine metabolism in Parkinson's disease

(2009) Nobutaka Hattori et al.   PARKINSONISM & RELATED DISORDERS

A flexible sequential learning deficit in patients with Parkinson’s disease: a 2 × 8 button-press task

(2009) Hiroko Mochizuki-Kawai et al.   EXPERIMENTAL BRAIN RESEARCH

WGCNA: an R package for weighted correlation network analysis

(2008) Peter Langfelder et al.   BMC BIOINFORMATICS

Meeting Report: Consensus Statement—Parkinson’s Disease and the Environment: Collaborative on Health and the Environment and Parkinson’s Action Network (CHE PAN) Conference 26–28 June 2007

(2008) Jeff Bronstein et al.   ENVIRONMENTAL HEALTH PERSPECTIVES

Olfactory deficits in mice overexpressing human wildtype -synuclein

(2008) Sheila M. Fleming et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Behavioural and neurochemical response of α-synuclein A30P transgenic mice to the effects of L-DOPA

(2008) Mari Oksman et al.   NEUROPHARMACOLOGY

Association of olfactory dysfunction with risk for future Parkinson's disease

(2007) G. Webster Ross et al.   ANNALS OF NEUROLOGY

Selective loss of nigral dopamine neurons induced by overexpression of truncated human α-synuclein in mice

(2006) Masaki Wakamatsu et al.   NEUROBIOLOGY OF AGING